Please try another search
Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in Taiwan and the United States. The company focuses on developing devices for minimally invasive surgeries, such as Duett, a vascular graft system; ClickClean, a solution to view throughout laparoscopic surgeries; AbClose to prevent port site herniation caused by improper closure; UroCross, an expander system; PUMA, a solution to treat orthopedic extremity injuries; and Cross-Seal, a large-bore closure device. It is involved in medical device contract manufacturing, equity investment and commerce of medical devices, manufacturing and sale of injection molding and components of medical devices. Medeon Biodesign, Inc. was incorporated in 2012 and is headquartered in Taipei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Yue-Teh Jang | - | 2012 | Chairman of the Board & CEO |
Jung-Chin Lin | 67 | 2014 | Representative Director |
Hong-Jen Chang | 65 | 2021 | Director |
Hsin-Yuan Fang | - | 2018 | Director |
Chih-Hang Yang | - | 2015 | Independent Director |
Chia-Ying Ma | 63 | 2015 | Independent Director |
Zhilong Shen | 57 | 2015 | Independent Director |
Chih-Hsiung Wu | - | 2016 | Representative Director |
Rongjin Lin | - | - | Board Director |
- Yeh | - | - | Independent Board Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review